BIONEER CORPORATION

Bioneer’s ‘CosmeRNA’ Advances into the U.S. Market with New Customer-Friendly Packaging

 

- Enhanced 2ml packaging for improved customer convenience

- Progressing smoothly with listing on Amazon U.S.

 

 

Bioneer announced on the 4th that its hair loss cosmetic, CosmeRNA (Hair Revitalizing Tonic CosmeRNA ARI), is making steady progress in entering the U.S. market with a newly upgraded packaging.

 

The new 2ml container addresses customer feedback regarding the previous 1ml syringe-style model, which some found challenging to control. The packaging has been improved with a button-operated dispensing mechanism for precise application. Additionally, the massage applicator has been upgraded to a round tip, allowing for convenient use at any angle and greatly enhancing user experience during application.

 

Bioneer is currently listing CosmeRNA on the U.S. Amazon platform. As the U.S. is considered a key market with growing demand for hair loss cosmetics and high purchasing power, this entry is expected to significantly contribute to the global revenue growth of CosmeRNA.

 

According to market research firm Data Bridge Market Research, the U.S. hair loss treatment market is projected to grow from approximately $1.95 billion in 2022 to around $3.08 billion by 2030, with a compound annual growth rate (CAGR) of 5.9%.

 

To facilitate entry into the U.S. market, Bioneer has completed the FDA MoCRA (The Modernization of Cosmetics Regulation Act) registration for safety and quality compliance. The patented key ingredient of CosmeRNA has already been listed in the International Cosmetic Ingredient Dictionary (ICID) published by the U.S. Cosmetics Association, fulfilling all requirements for local sales.

 

CosmeRNA ARI, which incorporates technology to reduce androgen receptor mRNA levels, a key contributor to hair loss, has also been developed and launched by Bioneer. This product was recognized as the Hair Product of the Year at Cosmoprof Awards 2024, one of the world’s largest cosmetics exhibitions, further validating its innovation in the global market.

 

A Bioneer representative stated, “The U.S. is one of the world’s largest hair loss markets and a strategically critical region. We have been meticulously preparing for this entry for a long time. By addressing customer needs with these improvements, we aim to further solidify our position in the global market.”